Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Menlo Care Landmark midline catheter adverse events will be evaluated in upcoming study.

This article was originally published in The Gray Sheet

Executive Summary

MENLO CARE LANDMARK MIDLINE CATHETER: COMPARATIVE ADVERSE EVENTS STUDY will be conducted in 1996, the company says in a Jan. 12 "device bulletin" sent to 1,500 physicians. The goal of the study is to ascertain the cause of a number of adverse events reported to the company for the Landmark catheters. Menlo Care notes that testing to date "has not indicated any sensitivity or allergy to the device material," but the firm is working with FDA to "to try to understand the nature of the events and how to prevent them."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005342

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel